Equity
€115,621 ▲ 151%
ODEPHARMA has made a profit without a break since 2017.
ODEPHARMA
Lifetime
19 annual accounts with figures on one time axis, 35 filings since 1991peak €223,178 (2025)
€223,178▲ 57.3%
lowest -€55,418 (2015)
€69,636▲ 725%
peak €115,621 (2025)
€115,621▲ 151%
€139,674▼ 22.9%
peak 2 FTE (2018)
1.9 FTE▲ 5.6%
Board4 names since 2017
1 director
Owners
Documentsfilings and deeds
03-02-202686 days before the deadline
2025abbreviated format
Gross margin from €141,917 to €223,178Result from €8,443 to €69,636Equity from €45,985 to €115,621Debts from €181,268 to €139,674Cash from €15,844 to €57,952
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as ODEPHARMA has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for ODEPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, , since 01-10-2024
- 99.52%equity €64,999 (2024) · 30-09-2023 annual accounts of
Recent changes
New establishment in Koksijde
APOTHEEK PHARMACIE, Leopold II Laan 57
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0441639812
Company renamed from APOTHEEK STAELENS - MOEYAERT to ODEPHARMA
Gazette deed
Registered office moved from De Panne to Oostduinkerke
New registered office: Leopold II Laan 168, 8670 Oostduinkerke · Previous registered office: Zeelaan 135, 8660 De Panne · Resignations: , and · General meeting of 01-10-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ODEPHARMA Koksijde | €255,295 | €223,178 | 45.3% | 1.9 |
| APOTHEEK DE VLASCHAARD Antwerp | €306,760 | €226,256 | 62.5% | 2.4 |
| PHARMALINE Courcelles | €339,554 | €190,260 | 1.9% | 2 |
| GROOT ZAND Dendermonde | €358,515 | €192,608 | 45.5% | 2 |
| Apotheek Saint-Germain Ypres | €335,523 | €127,398 | 53.2% | 1.6 |
| APOTHEEK DE GAPER Mortsel | €228,107 | €157,365 | 56.6% | 1.2 |
| APOTHEEK DRIE FONTEINEN Tervuren | €387,846 | €236,609 | 50.7% | 1.7 |
These companies have the same main activity as ODEPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €228,000 and €388,000, founded between 1983 and 1997.
Official details
Source: KBO- Status
- Active since 12-09-1990Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 30-09-2023
- Establishment units
- 2.049.732.2398670 Koksijde, since 08-10-1990
- 2.395.057.0888670 Koksijde, since 01-10-2026
- Financial year end
- 30 September
- Peppol
- Reachable since 02-10-2025
Annual accounts to 30-09-2025
- ≈ €1.0mestimated
- €255,295▲ 12.3%
- Employeeson 30-09-2025
- 2=
- Filing
- Filed on 03-02-2026, 86 days before the end of the filing period
Insights on ODEPHARMA
ODEPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €41,679 in 2007 to €223,178 in 2025.
holds all the shares. In October 2024, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ODEPHARMA
- What is the company number of ODEPHARMA?
- The company number of ODEPHARMA is 0441.639.812. The VAT number is the same number with BE in front: BE 0441.639.812.
- Where is ODEPHARMA based?
- The registered office is at Leopold II Laan 168, 8670 Koksijde.Company details
- What does ODEPHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of ODEPHARMA?
- ODEPHARMA is a public limited company (NV).
- When was ODEPHARMA founded?
- ODEPHARMA was founded on 12-09-1990.
- Is ODEPHARMA still active?
- Yes, ODEPHARMA is an active enterprise in the KBO register.
- How many employees does ODEPHARMA have?
- ODEPHARMA had an average of 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ODEPHARMA fall under?
- In its 30-09-2023 annual accounts, ODEPHARMA states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of ODEPHARMA?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €223,178 and 51 comparable companies (NACE 477). It probably lies between €700,000 and €2.0m.
- Is ODEPHARMA profitable?
- In financial year 2025, ODEPHARMA made a profit of €69,636.
- Where can I find the annual accounts of ODEPHARMA?
- ODEPHARMA filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ODEPHARMA due?
- ODEPHARMA must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.